{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T04:14:10Z","timestamp":1759032850452},"reference-count":40,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1016\/j.schres.2010.10.014","type":"journal-article","created":{"date-parts":[[2010,11,11]],"date-time":"2010-11-11T09:45:57Z","timestamp":1289468757000},"page":"93-102","source":"Crossref","is-referenced-by-count":29,"title":["The metabolic syndrome and its constituting variables in atypical antipsychotic-treated subjects: Comparison with other drug treatments, drug-free psychiatric patients, first-degree relatives and the general population in Venezuela"],"prefix":"10.1016","volume":"126","author":[{"given":"Trino","family":"Baptista","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Serrano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Euderruh","family":"Uzc\u00e1tegui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yamily","family":"ElFakih","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nairy","family":"Rangel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edgardo","family":"Carrizo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virginia","family":"Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisette","family":"Connell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enma Araujo","family":"de Baptista","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Segundo","family":"Quiroz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marycelvia","family":"Uzc\u00e1tegui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juana","family":"Rond\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yimber","family":"Matos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lilia","family":"Uzc\u00e1tegui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roald","family":"G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lenin","family":"Valery","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dar\u00edo","family":"Novoa-Montero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.schres.2010.10.014_bb0005","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s11845-008-0156-9","article-title":"Prevalence and associations of the metabolic syndrome among patients prescribed clozapine","volume":"177","author":"Ahmed","year":"2008","journal-title":"Ir. J. Med. Sci."},{"issue":"4","key":"10.1016\/j.schres.2010.10.014_bb0010","doi-asserted-by":"crossref","first-page":"215","DOI":"10.4088\/JCP.v60n0402","article-title":"The distribution of body mass index among individuals with and without schizophrenia","volume":"60","author":"Allison","year":"1999","journal-title":"J. Clin. Psychiatry"},{"issue":"11","key":"10.1016\/j.schres.2010.10.014_bb0015","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1176\/ajp.156.11.1686","article-title":"Antipsychotic-induced weight gain: a comprehensive research synthesis","volume":"156","author":"Allison","year":"1999","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2010.10.014_bb0020","series-title":"Diagnostic and Statistical Manual, DSMIV-TR","author":"American Psychiatric Association","year":"2000"},{"issue":"6","key":"10.1016\/j.schres.2010.10.014_bb0025","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1517\/14740338.4.6.1111","article-title":"Atypical antipsychotic drugs, diabetes and ethnicity","volume":"4","author":"Ananth","year":"2005","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.schres.2010.10.014_bb0030","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1176\/appi.ajp.2008.08071065","article-title":"Long-term use of antidepressants for depressive disorders and the risk of diabetes mellitus","volume":"166","author":"Andersohn","year":"2009","journal-title":"Am. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2010.10.014_bb0035","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1600-0447.1999.tb10908.x","article-title":"Obesity induced by antipsychotic drugs: mechanism and management","volume":"100","author":"Baptista","year":"1999","journal-title":"Acta Psychiatr. Scand."},{"issue":"2","key":"10.1016\/j.schres.2010.10.014_bb0040","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1055\/s-2007-979586","article-title":"Lithium and body weight gain","volume":"28","author":"Baptista","year":"1995","journal-title":"Pharmacopsychiatry"},{"issue":"7","key":"10.1016\/j.schres.2010.10.014_bb0045","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.eurpsy.2009.07.010","article-title":"Prevalence and awareness of cardiovascular risk factors in patients with schizophrenia: a cross-sectional study in a low cardiovascular disease risk geographical area","volume":"24","author":"Bernardo","year":"2009","journal-title":"Eur. Psychiatry"},{"issue":"1\u20133","key":"10.1016\/j.schres.2010.10.014_bb0050","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.schres.2006.09.025","article-title":"Cardiovascular and metabolic risk in outpatients with schizophrenia treated with antipsychotics: results of the CLAMORS Study","volume":"90","author":"Bobes","year":"2007","journal-title":"Schizophr. Res."},{"issue":"1\u20132","key":"10.1016\/j.schres.2010.10.014_bb0055","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jad.2008.12.018","article-title":"High prevalence of metabolic disturbances in patients with bipolar disorder in Taiwan","volume":"117","author":"Chang","year":"2009","journal-title":"J. Affect. Disord."},{"issue":"1\u20133","key":"10.1016\/j.schres.2010.10.014_bb0060","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.schres.2006.08.017","article-title":"Does antipsychotic polypharmacy increase the risk for metabolic syndrome?","volume":"89","author":"Correll","year":"2007","journal-title":"Schizophr. Res."},{"issue":"7","key":"10.1016\/j.schres.2010.10.014_bb0065","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1111\/j.1399-5618.2008.00625.x","article-title":"Equally increased risk for metabolic syndrome in patients with bipolar disorder and schizophrenia treated with second-generation antipsychotics","volume":"10","author":"Correll","year":"2008","journal-title":"Bipolar Disord."},{"issue":"1","key":"10.1016\/j.schres.2010.10.014_bb0070","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.schres.2005.12.855","article-title":"Prevalence of the metabolic syndrome in patients with schizophrenia treated with antipsychotic medication","volume":"83","author":"De Hert","year":"2006","journal-title":"Schizophr. Res."},{"issue":"1","key":"10.1016\/j.schres.2010.10.014_bb0075","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/j.2051-5545.2009.tb00199.x","article-title":"Metabolic syndrome in people with schizophrenia: a review","volume":"8","author":"De Hert","year":"2009","journal-title":"World Psychiatry"},{"issue":"2","key":"10.1016\/j.schres.2010.10.014_bb0080","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/JCP.0b013e318166f533","article-title":"Beyond the \u201chype\u201d on the association between metabolic syndrome and atypical antipsychotics the confounding effects of cohort, typical antipsychotics, severe mental illness, comedications, and comorbid Substance use","volume":"28","author":"De Leon","year":"2008","journal-title":"J. Clin. Psychopharmacol."},{"issue":"2","key":"10.1016\/j.schres.2010.10.014_bb0085","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.psychres.2009.04.015","article-title":"Depression and obesity: a metanalysis of community-based studies","volume":"178","author":"De Wit","year":"2010","journal-title":"Psychiatry Res."},{"issue":"1","key":"10.1016\/j.schres.2010.10.014_bb0090","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1590\/S1516-44462008000100014","article-title":"Brazilian Consensus on second-generation antipsychotics and metabolic disorders","volume":"30","author":"Elkis","year":"2008","journal-title":"Rev. Bras. Psiquiatr."},{"key":"10.1016\/j.schres.2010.10.014_bb0095","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1475-2840-8-52","article-title":"Prevalence of the Metabolic Syndrome in Latin America and its association with sub-clinical carotid atherosclerosis: the CARMELA cross-sectional study","volume":"8","author":"Escobedo","year":"2009","journal-title":"Cardiovasc. Diabetol."},{"issue":"3","key":"10.1016\/j.schres.2010.10.014_bb0100","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1080\/10401230802177722","article-title":"Elevated prevalence of obesity, metabolic syndrome, and cardiovascular risk factors in bipolar disorder","volume":"20","author":"Fiedorowicz","year":"2008","journal-title":"Ann. Clin. Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2010.10.014_bb0105","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.diabres.2004.11.018","article-title":"Prevalence and risk factors associated with the metabolic syndrome and dyslipidemia in white, black, Amerindians and mixed Hispanics in Zulia State Venezuela","volume":"69","author":"Florez","year":"2005","journal-title":"Diab. Res. Clin. Pract."},{"issue":"6","key":"10.1016\/j.schres.2010.10.014_bb0110","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1176\/appi.ajp.2009.09060802","article-title":"International consensus study of antipsychotic dosing","volume":"167","author":"Gardner","year":"2010","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2010.10.014_bb0115","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1016\/S0924-9338(10)71706-5","article-title":"Management of physical health in patients with schizophrenia: practical recommendations","volume":"2","author":"Heald","year":"2010","journal-title":"Eur Psychiatry Suppl."},{"issue":"82","key":"10.1016\/j.schres.2010.10.014_bb0120","first-page":"338","article-title":"Metabolic syndrome induced by antipsychotic drugs. The problem of obesity","volume":"19","author":"Jufe","year":"2008","journal-title":"Vertex"},{"key":"10.1016\/j.schres.2010.10.014_bb0125","first-page":"102","article-title":"Weight changes during treatment with phenothiazine derivatives","volume":"2","author":"Klett","year":"1960","journal-title":"J. Neuropsychiatry"},{"issue":"7","key":"10.1016\/j.schres.2010.10.014_bb0130","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1176\/appi.ajp.163.7.1273","article-title":"Prevalence of the metabolic syndrome among patients receiving clozapine","volume":"163","author":"Lamberti","year":"2006","journal-title":"Am. J. Psychiatry"},{"issue":"7","key":"10.1016\/j.schres.2010.10.014_bb0135","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.pnpbp.2010.06.029","article-title":"Patients taking medications for bipolar disorder are more prone to metabolic syndrome than Korea's general population","volume":"34","author":"Lee","year":"2010","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2010.10.014_bb0140","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.schres.2005.07.014","article-title":"Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III","volume":"80","author":"McEvoy","year":"2005","journal-title":"Schizophr. Res."},{"issue":"3","key":"10.1016\/j.schres.2010.10.014_bb0145","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.jad.2010.04.012","article-title":"Bipolar disorder and metabolic syndrome: an international perspective","volume":"126","author":"McIntyre","year":"2010","journal-title":"J. Affect. Disord."},{"issue":"1","key":"10.1016\/j.schres.2010.10.014_bb0150","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1600-0447.2008.01317.x","article-title":"The metabolic syndrome and schizophrenia","volume":"119","author":"Meyer","year":"2008","journal-title":"Acta Psychiatr. Scand."},{"issue":"3","key":"10.1016\/j.schres.2010.10.014_bb0155","doi-asserted-by":"crossref","first-page":"318","DOI":"10.4088\/JCP.08m04267","article-title":"The moderating impact of ethnicity on metabolic outcomes during treatment with olanzapine and aripiprazole in patients with schizophrenia","volume":"70","author":"Meyer","year":"2009","journal-title":"J. Clin. Psychiatry"},{"issue":"1\u20133","key":"10.1016\/j.schres.2010.10.014_bb0160","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.schres.2009.03.025","article-title":"Metabolic profiles of second-generation antipsychotics in early psychosis: findings from the CAFE study","volume":"111","author":"Patel","year":"2009","journal-title":"Schizophr. Res."},{"issue":"5","key":"10.1016\/j.schres.2010.10.014_bb0165","doi-asserted-by":"crossref","first-page":"559","DOI":"10.4088\/JCP.v66n0503","article-title":"A 4-fold risk of metabolic syndrome in patients with schizophrenia: the Northern Finland 1966 Birth Cohort study","volume":"66","author":"Saari","year":"2005","journal-title":"J. Clin. Psychiatry"},{"issue":"5","key":"10.1016\/j.schres.2010.10.014_bb0170","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/j.1399-5618.2008.00599.x","article-title":"Metabolic syndrome in bipolar disorder: a cross-sectional assessment of a Health Management Organization database","volume":"10","author":"Sicras","year":"2008","journal-title":"Bipolar Disord."},{"issue":"1","key":"10.1016\/j.schres.2010.10.014_bb0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.schres.2008.10.011","article-title":"Results of phase 3 of the CATIE schizophrenia trial","volume":"107","author":"Stroup","year":"2009","journal-title":"Schizophr. Res."},{"issue":"25","key":"10.1016\/j.schres.2010.10.014_bb0180","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","article-title":"Evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) Final Report","volume":"106","author":"Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection","year":"2002","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.schres.2010.10.014_bb0185","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/j.1399-5618.2007.00520.x","article-title":"Prevalence of diabetes and the metabolic syndrome in a sample of patients with bipolar disorder","volume":"10","author":"van Winkel","year":"2008","journal-title":"Bipolar Disord."},{"issue":"2","key":"10.1016\/j.schres.2010.10.014_bb0190","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1528-1167.2009.02206.x","article-title":"The metabolic syndrome in overweight epileptic patients treated with valproic acid","volume":"51","author":"Verrotti","year":"2010","journal-title":"Epilepsia"},{"issue":"3","key":"10.1016\/j.schres.2010.10.014_bb0195","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jad.2006.08.009","article-title":"Atypical antipsychotics related metabolic syndrome in bipolar patients","volume":"98","author":"Yumru","year":"2007","journal-title":"J. Affect. Disord."},{"issue":"3","key":"10.1016\/j.schres.2010.10.014_bb0200","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0022-3956(03)00018-9","article-title":"Epidemiology, implications and mechanisms underlying drug-induced weight gain in psychiatric patients","volume":"37","author":"Zimmermann","year":"2003","journal-title":"J. Psychiatr. Res."}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996410015896?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996410015896?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,4]],"date-time":"2023-06-04T05:15:06Z","timestamp":1685855706000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996410015896"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":40,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["S0920996410015896"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2010.10.014","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2011,3]]}}}